Literature DB >> 23386766

Relationship between glycosylated hemoglobin level and sciatic nerve block performance in diabetic patients.

Nezih Sertoz1, Mustafa N Deniz, Hilmi O Ayanoglu.   

Abstract

BACKGROUND: The objective of the present study was to explore the effects of deficiencies in glucose regulation on the onset, regression, and block performance times in a group of patients with diabetes-related foot problems.
METHODS: Forty-eight patients with American Society of Anesthetists physical status 2-4 undergoing foot and ankle surgery with a popliteal fossa block were prospectively studied. Patients were stratified into cohorts based on 3 groups according to their HbA1c levels: group 1 (n = 15), HbA1c 5%-6%; group 2 (n = 16), HbA1c 7%-8%; group 3 (n = 17), HbA1c 9%-10%. A standardized local anesthetic mixture containing 10 mL of 2% prilocaine and 10 mL of 0.5% levobupivacaine was used in all study groups. The primary outcome of the study was the time for regression of the sensory block.
RESULTS: The onset times of sensory and motor blocks in group 3 were significantly longer than those in groups 2 and 1. Motor block regression time differed significantly between groups (P = .04), being longer in group 3 compared with group 1. In group 3, the sensory block regression time and the time of first analgesic use were significantly longer than the times in groups 1 and 2.
CONCLUSIONS: We found that sensory block regression time was longer in diabetic patients with poor glycemic control than in the patients with better glycemic control. Longer block performance time, probably due to reduction in sensory and motor conduction velocity in diabetic patients with poor glycemic control, should be taken into consideration when peripheral nerve blocks are used. LEVEL OF EVIDENCE: Level II, prospective comparative study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23386766     DOI: 10.1177/1071100712460366

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  7 in total

1.  Comparison of pulpal anesthesia and cardiovascular parameters with lidocaine with epinephrine and lidocaine with clonidine after maxillary infiltration in type 2 diabetic volunteers.

Authors:  Marija S Milic; Bozidar Brkovic; Elena Krsljak; Dragica Stojic
Journal:  Clin Oral Investig       Date:  2015-10-01       Impact factor: 3.573

2.  Insulin Signaling in Bupivacaine-induced Cardiac Toxicity: Sensitization during Recovery and Potentiation by Lipid Emulsion.

Authors:  Michael R Fettiplace; Katarzyna Kowal; Richard Ripper; Alexandria Young; Kinga Lis; Israel Rubinstein; Marcelo Bonini; Richard Minshall; Guy Weinberg
Journal:  Anesthesiology       Date:  2016-02       Impact factor: 7.892

3.  Retrospective Analysis of 0.25% Bupivacaine for Ultrasound-Guided Infraclavicular and Supraclavicular Nerve Blocks in an Ambulatory Surgery Center.

Authors:  Benjamin Rachman; Alec Bigness; Rahul Mhaskar; Nathan Rachman
Journal:  Cureus       Date:  2022-07-28

4.  Comparison of Ultrasound-Guided Infraclavicular Brachial Plexus Block Sensorial Duration in Diabetic and Non-diabetic Patients: A Prospective Observational Study.

Authors:  Nur Canbolat; Tuğçe Yeniocak; Emine Aysu Salviz; Nukhet Sivrikoz; Kamil Mehmet Tuğrul; Kahraman Öztürk
Journal:  Turk J Anaesthesiol Reanim       Date:  2022-08

5.  Poly(lactic-co-glycolic acid) conduit for repair of injured sciatic nerve: A mechanical analysis.

Authors:  Tao Yu; Changfu Zhao; Peng Li; Guangyao Liu; Min Luo
Journal:  Neural Regen Res       Date:  2013-07-25       Impact factor: 5.135

6.  No difference in pain reduction after epidural steroid injections in diabetic versus nondiabetic patients: A retrospective cohort study.

Authors:  Francis Wong; Bahram Namdari; Suzanne Dupler; Mario Farias Kovac; Natalya Makarova; Jarrod E Dalton; Alparslan Turan
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2016 Jan-Mar

7.  Diabetic neuropathy increases stimulation threshold during popliteal sciatic nerve block.

Authors:  S Heschl; B Hallmann; T Zilke; G Gemes; M Schoerghuber; M Auer-Grumbach; F Quehenberger; P Lirk; Q Hogan; M Rigaud
Journal:  Br J Anaesth       Date:  2016-04       Impact factor: 9.166

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.